Incyte Corp. sell BMO Capital Markets
Start price
02.07.24
/
50%
€54.76
Target price
02.07.25
€44.72
Performance (%)
-3.43%
Price
05.07.24
€52.88
Summary
This prediction is currently active. With a performance of -3.43%, the SELL prediction for Incyte Corp. by BMO_Capital_Markets is down slightly. This prediction currently runs until 02.07.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Incyte Corp. | -3.43% |
| iShares Core DAX® | 1.395% |
| iShares Nasdaq 100 | 2.287% |
| iShares Nikkei 225® | 1.617% |
| iShares S&P 500 | 0.659% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Co. (NASDAQ: INCY) had its "underperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, down previously from $52.00.
Ratings data for INCY provided by MarketBeat